206 related articles for article (PubMed ID: 24834583)
21. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
Yong C; Fisher DA; Sklar GE; Li SC
Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
[TBL] [Abstract][Full Text] [Related]
22. Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience.
Seaton RA; Gonzalez-Ramallo VJ; Prisco V; Marcano-Lozada M; Gonzalez-Ruiz A; Gallegos B; Menichetti F; Loeffler J; Bouylout K; Chaves RL
Int J Antimicrob Agents; 2013 May; 41(5):468-72. PubMed ID: 23473943
[TBL] [Abstract][Full Text] [Related]
23. Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting.
White HA; Davis JS; Kittler P; Currie BJ
Intern Med J; 2011 Sep; 41(9):668-73. PubMed ID: 20002854
[TBL] [Abstract][Full Text] [Related]
24. Outpatient parenteral antimicrobial therapy is safe and effective for the treatment of infective endocarditis: a retrospective cohort study.
Htin AK; Friedman ND; Hughes A; O'Brien DP; Huffam S; Redden AM; Athan E
Intern Med J; 2013 Jun; 43(6):700-5. PubMed ID: 23347167
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM;
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004
[TBL] [Abstract][Full Text] [Related]
26. Impact of an outpatient parenteral antimicrobial treatment (OPAT) as part of a paediatric-specific PROA program.
Fernández-Polo A; Ramon-Cortes S; Plaja-Dorca J; Bartolomé-Comas R; Vidal-Valdivia L; Soler-Palacín P;
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Apr; 41(4):230-234. PubMed ID: 35961853
[TBL] [Abstract][Full Text] [Related]
27. Risk of venous thromboembolism in patients treated for bacterial infection in the community with outpatient parenteral antimicrobial therapy.
Barr DA; Irvine S; Ritchie ND; McCutcheon J; Seaton RA
QJM; 2014 Mar; 107(3):207-11. PubMed ID: 24300160
[TBL] [Abstract][Full Text] [Related]
28. Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
Means L; Bleasdale S; Sikka M; Gross AE
Pharmacotherapy; 2016 Aug; 36(8):934-9. PubMed ID: 27393717
[TBL] [Abstract][Full Text] [Related]
29. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy.
Lacroix A; Revest M; Patrat-Delon S; Lemaître F; Donal E; Lorléac'h A; Arvieux C; Michelet C; Tattevin P
Med Mal Infect; 2014 Jul; 44(7):327-30. PubMed ID: 25022891
[TBL] [Abstract][Full Text] [Related]
30. Delivery, setting and outcomes of paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): a scoping review.
Carter B; Carrol ED; Porter D; Peak M; Taylor-Robinson D; Fisher-Smith D; Blake L
BMJ Open; 2018 Nov; 8(11):e021603. PubMed ID: 30446572
[TBL] [Abstract][Full Text] [Related]
31. Infectious Diseases Specialty Intervention Is Associated With Better Outcomes Among Privately Insured Individuals Receiving Outpatient Parenteral Antimicrobial Therapy.
Shah A; Petrak R; Fliegelman R; Shrestha N; Allison G; Zurlo J; Parker S; Poretz D; McKinsey D; Dougherty M; Martinelli L; Mathur A; Rodriguez A; Smith MW
Clin Infect Dis; 2019 Mar; 68(7):1160-1165. PubMed ID: 30247512
[TBL] [Abstract][Full Text] [Related]
32. Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on.
Chambers ST; Basevi A; Gallagher K; Carswell-Moyna A; Isenman H; Pithie A; Dalton S; Metcalf SC
N Z Med J; 2019 Aug; 132(1501):21-32. PubMed ID: 31465324
[TBL] [Abstract][Full Text] [Related]
33. Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.
Durojaiye OC; Slucka A; Kritsotakis EI
Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):941-949. PubMed ID: 35556187
[TBL] [Abstract][Full Text] [Related]
34. [Design and implementation of an outpatient parenteral antimicrobial therapy program in primary care: the experience at a second level hospital].
Ruiz-Campuzano M; García-Vázquez E; Hernández-Roca JJ; Gómez-Gómez J; Canteras-Jordana M; Mené-Fenor E; Hernández-Torres A; Peláez-Ballesta A
Rev Esp Quimioter; 2017 Feb; 30(1):19-27. PubMed ID: 27898208
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
[TBL] [Abstract][Full Text] [Related]
36. Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people.
Mujal A; Sola J; Hernandez M; Villarino MA; Baylina M; Tajan J; Oristrell J
J Antimicrob Chemother; 2016 May; 71(5):1402-7. PubMed ID: 26832749
[TBL] [Abstract][Full Text] [Related]
37. Outpatient parenteral antimicrobial therapy today.
Paladino JA; Poretz D
Clin Infect Dis; 2010 Sep; 51 Suppl 2():S198-208. PubMed ID: 20731577
[TBL] [Abstract][Full Text] [Related]
38. Discharge Delays and Costs Associated With Outpatient Parenteral Antimicrobial Therapy for High-Priced Antibiotics.
Bianchini ML; Kenney RM; Lentz R; Zervos M; Malhotra M; Davis SL
Clin Infect Dis; 2020 Oct; 71(7):e88-e93. PubMed ID: 31665269
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the effectiveness, safety and costs of outpatient intravenous antimicrobial treatment (OPAT) vs hospitalized in urinary infection in pediatrics].
Peña A; Zambrano A; Alvarado M; Cerda J; Vergara R
Rev Chilena Infectol; 2013 Aug; 30(4):426-34. PubMed ID: 24248113
[TBL] [Abstract][Full Text] [Related]
40. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.
Gilchrist M; Seaton RA
J Antimicrob Chemother; 2015 Apr; 70(4):965-70. PubMed ID: 25538169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
